Literature DB >> 28508679

Comparison of FDG PET metabolic tumour volume versus ADC histogram: prognostic value of tumour treatment response and survival in patients with locally advanced uterine cervical cancer.

Yoshiko Ueno1,2, Robert Lisbona3, Tsutomu Tamada4, Amer Alaref1, Kazuro Sugimura2, Caroline Reinhold1.   

Abstract

OBJECTIVE: To evaluate the prognostic utility of volume-based parameters of fluorine-18 fludeoxyglucose positron emission tomography (18F-FDG PET) and apparent diffusion coefficient (ADC) histogram analysis for tumour response to therapy and event-free survival (EFS) in patients with uterine cervical cancer receiving chemoradiotherapy.
METHODS: The study included 21 patients diagnosed with locally advanced uterine cervical cancer who underwent pre-treatment MRI and 18F-FDG PET and were treated with concurrent chemoradiotherapy. 18F-FDG parameters: maximum and mean standardized uptake value; metabolic tumour volume (MTV); total lesion glycolysis (TLG); ADC parameters: maximum, mean and minimum values; percentile ADC values (10-90%); skewness and kurtosis of ADC were measured and compared between the responder and non-responder groups using a Wilcoxon rank-sum test. The Cox regression analysis and Kaplan-Meier survival curves were performed for EFS analysis.
RESULTS: MTV and TLG of the primary tumour were significantly higher in the non-responder group than in the responder group (p = 0.04 and p = 0.01). Applying Cox regression multivariate analysis, MTV [hazard ratio (HR), 4.725; p = 0.036], TLG (HR, 4.725; p = 0.036) and 10-percentile ADC (HR, 5.207; p = 0.048) showed a statistically significant association with EFS. With the optimal cut-off value, the EFS rates above the cut-off value for MTV and TLG were significantly lower than that below the cut-off value (p = 0.002 and p = 0.002).
CONCLUSION: Pre-treatment volume-based quantitative parameters of 18F-FDG PET may have better potential than ADC histogram for predicting treatment response and EFS in patients with locally advanced cervical cancer. Advances in knowledge: In this study, pre-treatment volume-based quantitative parameters of 18F-FDG PET had better potential than ADC histogram for predicting treatment response and survival in patients with locally advanced cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28508679      PMCID: PMC5594985          DOI: 10.1259/bjr.20170035

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  33 in total

1.  Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment.

Authors:  Whitney B Pope; Hyun J Kim; Jing Huo; Jeffry Alger; Matthew S Brown; David Gjertson; Victor Sai; Jonathan R Young; Leena Tekchandani; Timothy Cloughesy; Paul S Mischel; Albert Lai; Phioanh Nghiemphu; Syed Rahmanuddin; Jonathan Goldin
Journal:  Radiology       Date:  2009-07       Impact factor: 11.105

2.  Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients.

Authors:  Dow-Mu Koh; Erica Scurr; David Collins; Baris Kanber; Andrew Norman; Martin O Leach; Janet E Husband
Journal:  AJR Am J Roentgenol       Date:  2007-04       Impact factor: 3.959

3.  Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging--correlation with tumor grade.

Authors:  Yusuhn Kang; Seung Hong Choi; Young-Jae Kim; Kwang Gi Kim; Chul-Ho Sohn; Ji-Hoon Kim; Tae Jin Yun; Kee-Hyun Chang
Journal:  Radiology       Date:  2011-10-03       Impact factor: 11.105

4.  Evaluation of therapeutic response to concurrent chemoradiotherapy in patients with cervical cancer using diffusion-weighted MR imaging.

Authors:  Hyun Su Kim; Chan Kyo Kim; Byung Kwan Park; Seung Jae Huh; Bohyun Kim
Journal:  J Magn Reson Imaging       Date:  2012-09-27       Impact factor: 4.813

5.  Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.

Authors:  W A Peters; P Y Liu; R J Barrett; R J Stock; B J Monk; J S Berek; L Souhami; P Grigsby; W Gordon; D S Alberts
Journal:  J Clin Oncol       Date:  2000-04       Impact factor: 44.544

6.  Diffusion-weighted magnetic resonance imaging of uterine cervical cancer.

Authors:  Ying Liu; Renju Bai; Haoran Sun; Haidong Liu; Dehua Wang
Journal:  J Comput Assist Tomogr       Date:  2009 Nov-Dec       Impact factor: 1.826

Review 7.  New trends in the evaluation and treatment of cervix cancer: the role of FDG-PET.

Authors:  Nicolas Magné; Cyrus Chargari; Lisa Vicenzi; Norman Gillion; Taha Messai; Jacques Magné; Gérald Bonardel; Christine Haie-Meder
Journal:  Cancer Treat Rev       Date:  2008-10-11       Impact factor: 12.111

Review 8.  Diffusion-weighted MRI in the body: applications and challenges in oncology.

Authors:  Dow-Mu Koh; David J Collins
Journal:  AJR Am J Roentgenol       Date:  2007-06       Impact factor: 3.959

9.  Diffusion-weighted MRI in cervical cancer.

Authors:  Patrick Z McVeigh; Aejaz M Syed; Michael Milosevic; Anthony Fyles; Masoom A Haider
Journal:  Eur Radiol       Date:  2008-01-12       Impact factor: 5.315

10.  Pre-treatment diffusion-weighted MR imaging for predicting tumor recurrence in uterine cervical cancer treated with concurrent chemoradiation: value of histogram analysis of apparent diffusion coefficients.

Authors:  Suk Hee Heo; Sang Soo Shin; Jin Woong Kim; Hyo Soon Lim; Yong Yeon Jeong; Woo Dae Kang; Seok Mo Kim; Heoung Keun Kang
Journal:  Korean J Radiol       Date:  2013-07-17       Impact factor: 3.500

View more
  9 in total

1.  Studying local tumour heterogeneity on MRI and FDG-PET/CT to predict response to neoadjuvant chemoradiotherapy in rectal cancer.

Authors:  Niels W Schurink; Simon R van Kranen; Maaike Berbee; Wouter van Elmpt; Frans C H Bakers; Sander Roberti; Joost J M van Griethuysen; Lisa A Min; Max J Lahaye; Monique Maas; Geerard L Beets; Regina G H Beets-Tan; Doenja M J Lambregts
Journal:  Eur Radiol       Date:  2021-02-10       Impact factor: 5.315

2.  Value of combined multiparametric MRI and FDG-PET/CT to identify well-responding rectal cancer patients before the start of neoadjuvant chemoradiation.

Authors:  Niels W Schurink; Lisa A Min; Maaike Berbee; Wouter van Elmpt; Joost J M van Griethuysen; Frans C H Bakers; Sander Roberti; Simon R van Kranen; Max J Lahaye; Monique Maas; Geerard L Beets; Regina G H Beets-Tan; Doenja M J Lambregts
Journal:  Eur Radiol       Date:  2020-02-07       Impact factor: 5.315

3.  Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.

Authors:  Gigin Lin; Lan-Yan Yang; Yu-Chun Lin; Yu-Ting Huang; Feng-Yuan Liu; Chun-Chieh Wang; Hsin-Ying Lu; Hsin-Ju Chiang; Yu-Ruei Chen; Ren-Chin Wu; Koon-Kwan Ng; Ji-Hong Hong; Tzu-Chen Yen; Chyong-Huey Lai
Journal:  Eur Radiol       Date:  2018-07-26       Impact factor: 5.315

4.  The role of 18F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospective study.

Authors:  Vittoria Rufini; Angela Collarino; Maria Lucia Calcagni; Guido Maria Meduri; Valentina Fuoco; Tina Pasciuto; Antonia Carla Testa; Gabriella Ferrandina; Maria Antonietta Gambacorta; Maura Campitelli; Benedetta Gui; Gianfranco Zannoni; Riccardo Manfredi; Giovanni Scambia; Alessandro Giordano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-14       Impact factor: 9.236

5.  Chemoradiotherapy for locally advanced cervix cancer without aortic lymph node involvement: can we consider metabolic parameters of pretherapeutic FDG-PET/CT for treatment tailoring?

Authors:  Marie Voglimacci; Erwan Gabiache; Amélie Lusque; Gwenaël Ferron; Anne Ducassou; Denis Querleu; Stéphanie Motton; Elodie Chantalat; Frédéric Courbon; Alejandra Martinez
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-02-07       Impact factor: 9.236

6.  Prognostic value of posttreatment 18F-FDG PET/CT and predictors of metabolic response to therapy in patients with locally advanced cervical cancer treated with concomitant chemoradiation therapy: an analysis of intensity- and volume-based PET parameters.

Authors:  Giacomo Maria Lima; Antonella Matti; Giulio Vara; Giulia Dondi; Nicoletta Naselli; Eugenia Maria De Crescenzo; Alessio Giuseppe Morganti; Anna Myriam Perrone; Pierandrea De Iaco; Cristina Nanni; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-02       Impact factor: 9.236

7.  Cervical Cancer: Associations between Metabolic Parameters and Whole Lesion Histogram Analysis Derived from Simultaneous 18F-FDG-PET/MRI.

Authors:  Hans-Jonas Meyer; Sandra Purz; Osama Sabri; Alexey Surov
Journal:  Contrast Media Mol Imaging       Date:  2018-07-30       Impact factor: 3.161

8.  Whole lesion histogram analysis of apparent diffusion coefficients on MRI predicts disease-free survival in locally advanced squamous cell cervical cancer after radical chemo-radiotherapy.

Authors:  Bo Zhao; Kun Cao; Xiao-Ting Li; Hai-Tao Zhu; Ying-Shi Sun
Journal:  BMC Cancer       Date:  2019-11-15       Impact factor: 4.430

Review 9.  A decade of multi-modality PET and MR imaging in abdominal oncology.

Authors:  Lisa A Min; Francesca Castagnoli; Wouter V Vogel; Jisk P Vellenga; Joost J M van Griethuysen; Max J Lahaye; Monique Maas; Regina G H Beets Tan; Doenja M J Lambregts
Journal:  Br J Radiol       Date:  2021-08-13       Impact factor: 3.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.